期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 115, 期 7, 页码 1828-1838出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI22954
关键词
-
资金
- NIAID NIH HHS [R01 AI062261, R01 AI62261-01-1, R01 AI40384, R01 AI040384] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
Inhibitors of HIV protease have been shown to have antiapoptotic effects in vitro, yet whether these effects are seen in vivo remains controversial. in this study, we have evaluated the impact of the HIV protease inhibitor (PI) nelfinavir, boosted with ritonavir, in models of nonviral disease associated with excessive apoptosis. In mice with Fas-induced fatal hepatitis, Staphylococcal enterotoxin B-induced shock, and middle cerebral artery occlusion-induced stroke, we demonstrate that Pis significantly reduce apoptosis and improve histology, function, and/or behavioral recovery in each of these models. Further, we demonstrate that both in vitro and in vivo, Pis block apoptosis through the preservation of mitochondrial integrity and that in vitro Pis act to prevent pore function of the adenine nucleotide translocator (ANT) subunit of the mitochondrial permeability transition pore complex.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据